Loring Wolcott & Coolidge Fiduciary Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-192
Closed -$23.2K 563
2025
Q1
$23.2K Buy
+192
New +$25.3K ﹤0.01% 434

Other funds holding THC

Loring Wolcott & Coolidge Fiduciary Advisors's THC Position: Q2 2025 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 192 shares — an estimated $23.2K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in THC in Q1 2025 and held it in 1 quarter. The position peaked at $23.2K in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 192 Tenet Healthcare shares in Q2 2025, an estimated $23.2K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Tenet Healthcare in Q1 2025 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Tenet Healthcare position peaked at $23.2K in Q1 2025.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.